ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 257 filers reported holding ALKERMES PLC in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,021,000 | +65.5% | 27,977 | +33.8% | 0.00% | +100.0% |
| Q4 2018 | $617,000 | -13.7% | 20,915 | +24.2% | 0.00% | 0.0% |
| Q3 2018 | $715,000 | +11.7% | 16,842 | +8.2% | 0.00% | 0.0% |
| Q2 2018 | $640,000 | +4.9% | 15,562 | +47.8% | 0.00% | 0.0% |
| Q1 2018 | $610,000 | +23.0% | 10,526 | +16.2% | 0.00% | 0.0% |
| Q4 2017 | $496,000 | +50.8% | 9,056 | +40.0% | 0.00% | 0.0% |
| Q3 2017 | $329,000 | +201.8% | 6,470 | +245.1% | 0.00% | – |
| Q2 2017 | $109,000 | +12.4% | 1,875 | +12.7% | 0.00% | – |
| Q1 2017 | $97,000 | +32.9% | 1,663 | +26.7% | 0.00% | – |
| Q4 2016 | $73,000 | +160.7% | 1,313 | +59.5% | 0.00% | – |
| Q1 2016 | $28,000 | – | 823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |